Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ethics and Bioethics01:22

Ethics and Bioethics

Ethics is a philosophical study of moral actions. Ethics attempts to determine what is valuable for individuals and society. It examines the rational justification of moral judgments and analyzes what is morally just, fair, and right. Bioethics is a sub-discipline of applied ethics that analyzes the philosophical, social, and legal issues in life sciences and medicine. Ethical theories serve as a foundation for decision-making and represent the viewpoints from which people seek direction. They...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Interdisciplinary Care: The Health Care Team-II01:18

Interdisciplinary Care: The Health Care Team-II

An interdisciplinary team includes many healthcare professionals working together and utilizing their skills, knowledge, and expertise to provide holistic and quality patient care. Here are a few more healthcare professionals.
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum: Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability.

Nature communications·2017
Same author

Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability.

Nature communications·2016
Same author

Heart Disease Prevention in Young Women: Sounding an Alarm.

Circulation·2015
Same author

Oxido-reductive regulation of vascular remodeling by receptor tyrosine kinase ROS1.

The Journal of clinical investigation·2014
Same author

Acceptance of the 2014 Association of American Physicians George M. Kober Medal. Giving back.

The Journal of clinical investigation·2014
Same author

The Women's Health Initiative--a victory for women and their health.

JAMA·2013
Same journal

Extracellular matrix reprogramming by the YAP/TAZ- TGF-ß2 axis drives immune exclusion in cholangiocarcinoma models.

The Journal of clinical investigation·2026
Same journal

Tumor cell-derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancer.

The Journal of clinical investigation·2026
Same journal

Julie Zikherman receives the ASCI/Marian W. Ropes, MD, Award.

The Journal of clinical investigation·2026
Same journal

Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma models.

The Journal of clinical investigation·2026
Same journal

SGLT2 inhibitors enhance ketogenesis by acting as allosteric activators of the mitochondrial enzyme HMGCS2.

The Journal of clinical investigation·2026
Same journal

MDM2 degraders for Merkel cell carcinoma: round peg in a round hole.

The Journal of clinical investigation·2026
See all related articles

Related Experiment Video

Updated: Jul 6, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

The physician-scientist: a value proposition.

Elizabeth G Nabel1

  • 1National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland 20892, USA. nabele@nih.gov

The Journal of Clinical Investigation
|April 3, 2008
PubMed
Summary
This summary is machine-generated.

The American Society for Clinical Investigation (ASCI) has supported physician-scientist careers for a century. Looking ahead, the ASCI must champion physician-scientist research and advocate for biomedical research funding.

More Related Videos

Using Micro-Electro-Mechanical Systems (MEMS) to Develop Diagnostic Tools
16:05

Using Micro-Electro-Mechanical Systems (MEMS) to Develop Diagnostic Tools

Published on: October 1, 2007

Related Experiment Videos

Last Updated: Jul 6, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Using Micro-Electro-Mechanical Systems (MEMS) to Develop Diagnostic Tools
16:05

Using Micro-Electro-Mechanical Systems (MEMS) to Develop Diagnostic Tools

Published on: October 1, 2007

Area of Science:

  • Medical research
  • Physician-scientist training

Background:

  • The American Society for Clinical Investigation (ASCI) has a 100-year history of supporting physician-scientists.
  • The evolving landscape of biomedical research necessitates a forward-thinking approach.

Purpose of the Study:

  • To outline the ASCI's future role in advancing physician-scientist careers.
  • To emphasize the need for public advocacy in biomedical research.

Main Methods:

  • This is a perspective piece, not a research study.
  • It reflects on the historical contributions of the ASCI.
  • It proposes future directions for the organization.

Main Results:

  • The ASCI has a strong legacy in supporting physician-scientists.
  • There is a critical need for continued advancement in physician-scientist research.
  • Public advocacy is essential for the future of biomedical research.

Conclusions:

  • The ASCI must continue to be a leader in physician-scientist development.
  • The organization should actively engage in public advocacy for biomedical research.
  • Sustained support is crucial for the progress of medical innovation.